投资组合情况 - 公司总投资组合的公允价值为35.69亿美元[301] - 公司在2024年上半年共完成了13.05亿美元的新投资承诺[303] - 公司在2024年上半年共完成了8.30亿美元的债务投资[303] - 公司在2024年上半年共完成了0.68亿美元的股权和投资基金投资[303] - 公司在2024年6月30日的未偿还合同承诺为4.80亿美元[303] - 公司投资组合的总投资活动净变动为3.21亿美元增加[305] - 公司在2024年上半年新增投资承诺中有3.37亿美元被分配给或直接由顾问基金承接[303] - 公司在2024年上半年新增投资中有2.29亿美元被分配给或直接由顾问基金承接[303] - 公司在2024年6月30日的未偿还合同承诺中有1.26亿美元被分配给或直接由顾问基金承接[303] - 公司投资组合中"药物发现与开发"、"软件"、"其他医疗服务"和"消费者与商业服务"四大行业占比超过90%[2] - 公司十大投资组合公司占总投资组合公允价值的30%[2] - 公司有5项投资占净资产5%以上[2] - 公司有4项股权投资占股权投资组合公允价值的51.9%[2] 债务投资组合情况 - 公司债务投资组合的加权平均核心收益率为13.7%[1] - 公司债务投资组合的加权平均实际收益率为14.7%[1] - 公司债务投资组合中97.4%为浮动利率[1] - 公司债务投资组合的加权平均投资评级为2.18，较2023年12月31日的2.24有所下降[321] - 截至2024年6月30日，公司表现良好的债务投资占总投资组合的97.5%，非应计投资占2.5%[323] 股票认购权证投资 - 公司持有101家投资组合公司的股票认购权证,公允价值约2890万美元[1] - 公司已实现的股票认购权证投资回报率在1.02倍到42.71倍之间[3] 投资收益和运营费用 - 2024年上半年总投资收益为2.47亿美元，同比增长11.4%，主要由于加权平均本金增加和股息收入增加[325,329,332] - 2024年上半年利息和股息收入为2.33亿美元，同比增长11.7%，其中PIK利息收入增加带动了总利息收入的增长[330,332,335] - 2024年上半年费用收入为1,325万美元，同比增长6.5%，主要由于到期承诺费用和提前还款加速费用的增加[336] - 2024年上半年运营费用为8,504万美元，同比增加6.1%，主要由于债务利息和费用增加[338,339,340] - 公司一般及行政费用和税务费用有所下降[341] - 员工薪酬总额有所增加，主要由于浮动薪酬的增加[342] - 分摊给子公司的费用有所增加，主要由于管理资产规模增加和分摊给子公司基金的费用增加[343] 其他财务信息 - 公司计划将大部分年度应税收益及时分配给股东[354] - 子公司获得的管理费收入和利息收入有所增加[355][356] - 公司主要通过债务借款和经营现金流提供流动性和资本资源[357] - 公司在六月三十日有4.82亿美元可用流动性，包括2,770万美元现金和等价物以及在信贷额度下的可用借款[357] - 公司还可通过信贷额度的增加条款获得4.75亿美元额外借款额度，以及SBIC V许可证获得1.75亿美元SBA债券[357] - 公司资产负债率为216.7%，不包括SBA债券，包括SBA债券为205.4%[358] - 公司可能通过公开发行或私募发行股票、资产证券化等方式筹集额外股权或债务资本[357] - 公司在三个月和六个月内通过股票发行分别获得0和6,640万美元净募集资金[360] - 公司在六月三十日有4.795亿美元未使用的承诺[362] 风险管理 - 公司不参与套期保值活动，但可能会使用期货、期权和远期合同等标准套期保值工具来对冲利率波动和外汇风险[366] - 公司的净投资收益取决于借款利率和投资收益率之间的差异，利率大幅变动可能会对净投资收益产生重大不利影响[366] 内部控制 - 公司的披露控制和程序被认为是有效的，可确保及时披露所需信息[367] - 公司内部控制报告期内未发生重大变化[368] 诉讼 - 公司可能会涉及正常业务过程中的诉讼，但目前不预期会对财务状况或经营业绩产生重大影响[369]

In the last reported quarter, the company's earnings surpassed the Zacks Consensus Estimate. Results were primarily aided by an increase in total investment income. Also, the balance sheet position was strong and new commitments were robust. However, a rise in operating expenses was a headwind. Q2 Earnings & Sales Estimates The consensus estimate for sales of $125 million suggests a 7.5% year-over-year increase. Given the current high-interest rate environment, HTGC is expected to have benefited from an inc ...

Analysts on Wall Street project that Hercules Capital (HTGC) will announce quarterly earnings of $0.51 per share in its forthcoming report, representing a decline of 3.8% year over year. Revenues are projected to reach $124.99 million, increasing 7.5% from the same quarter last year. Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empir ...

Alones Creative Management Expense Alignment With Shareholders In an externally managed BDC, these fees can add up to about 1/4 of the gross investment income provided by the asset portfolio. HTGC avoids this overhead cost and passes the savings on to the shareholder. This is one reason why HTGC currently trades at a large premium to NAV. We compute the debt-to-equity ratio for FY end 2014-2023 for HTGC. All figures used are in millions of USD and were extracted from past 10-K filings. The debt-toequity rat ...

This additional funding comes at an instrumental time for Pindrop as the company continues to innovate groundbreaking voice security and authentication solutions ATLANTA, July 17, 2024 /PRNewswire/ -- Pindrop, a global leader in voice authentication and security, today announced it has secured $100 million in debt financing from Hercules Capital, Inc. (NYSE: HTGC). This significant funding will enable Pindrop to further develop its cutting-edge audio, voice, and AI technologies, enhancing its offerings for ...

Analysts and investors alike will be keeping a close eye on the performance of Hercules Capital in its upcoming earnings disclosure. In that report, analysts expect Hercules Capital to post earnings of $0.51 per share. This would mark a year-over-year decline of 3.77%. Meanwhile, the latest consensus estimate predicts the revenue to be $124.99 million, indicating a 7.53% increase compared to the same quarter of the previous year. Our research shows that these estimate changes are directly correlated with ne ...

Prior to today's trading, shares of the specialty finance company had gained 4.08% over the past month. This has outpaced the Finance sector's loss of 0.57% and the S&P 500's gain of 3.38% in that time. In terms of valuation, Hercules Capital is currently trading at a Forward P/E ratio of 9.78. This valuation marks a premium compared to its industry's average Forward P/E of 8.2. In the latest trading session, Hercules Capital (HTGC) closed at $20.28, marking a +0.65% move from the previous day. The stock ex ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sellside) analysts often affect a stock's price, do they really matter? Hercules Capital currently has an average brokerage recommendation (ABR) of 1.89, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by nine brokerage firms. A ...

Hercules Capital (HTGC) ended the recent trading session at $19.82, demonstrating a +0.1% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily loss of 0.16%. Elsewhere, the Dow gained 0.04%, while the tech-heavy Nasdaq lost 0.18%. The investment community will be closely monitoring the performance of Hercules Capital in its forthcoming earnings report. The company is predicted to post an EPS of $0.51, indicating a 3.77% decline compared to the equivalent ...

Analysts and investors alike will be keeping a close eye on the performance of Hercules Capital in its upcoming earnings disclosure. In that report, analysts expect Hercules Capital to post earnings of $0.51 per share. This would mark a year-over-year decline of 3.77%. Meanwhile, our latest consensus estimate is calling for revenue of $124.99 million, up 7.53% from the prior-year quarter. Our research shows that these estimate changes are directly correlated with near-term stock prices. To capitalize on thi ...